JP Morgan Chase
NVNO

JP Morgan Chase’s enVVeno Medical NVNO Stock Holding History

JP Morgan Chase’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$52.9K Hold
5,209
– – ﹤0.01% 6173
2025
Q4 		$58.5K Hold
5,209
– – ﹤0.01% 6164
2025
Q3 		$165K Hold
5,209
– – ﹤0.01% 5618
2025
Q2 		$727K Sell
5,209
-340
-6% -$40.2K ﹤0.01% 4572
2025
Q1 		$511K Sell
5,549
-2,166
-28% -$241K ﹤0.01% 4765
2024
Q4 		$816K Buy
+7,715
New +$862K ﹤0.01% 4765
2023
Q4 		– Hold
0
– -$59 – 7764
2023
Q3 		– Hold
0
– – – 6974

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase's NVNO Position: Q1 2026 in Review

JP Morgan Chase held its enVVeno Medical (NVNO) position steady in Q1 2026 at 5,209 shares worth $52.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6173.

JP Morgan Chase first reported a position in NVNO in Q4 2024 and has held it in 6 quarters since. The position peaked at $816K in Q4 2024. 17 funds tracked by Wall St. Rank hold NVNO as of Q1 2026.

  • JP Morgan Chase held 5,209 shares of enVVeno Medical worth $52.9K as of Q1 2026.
  • JP Morgan Chase left its enVVeno Medical share count unchanged in Q1 2026.
  • enVVeno Medical made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6173 holding.
  • JP Morgan Chase first reported a position in enVVeno Medical in Q4 2024 and has held it in 6 quarters since.
  • JP Morgan Chase's enVVeno Medical position peaked at $816K in Q4 2024.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.